Quadrant Capital »

Cullinan Oncology shares owned by Quadrant Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5k 241 10.19
2022-12-31 $6.7k 631 10.55

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Target Corporation (TGT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Quadrant Capital

Top funds holding Cullinan Oncology

Blue Owl Capital Holdings
Franklin Resources
BVF
Vanguard Group
Braidwell
American International
Nextech Invest
Citadel Advisors
Dimensional Fund Advisors
Tang Capital Management
Deutsche Bank Aktiengesellschaft
OrbiMed Advisors
Charles Schwab Investment Management
Millennium Management
Hudson Bay Capital Management

View all funds holding Cullinan Oncology